PharmaCyte Biotech, Inc. (85) | Human Resources (5)

Browse by Subcategory

Bonus & Incentive Agreements (1 contract)
Compensation Agreements (3)
Consulting Agreements (1)

Recent Contracts

Separation, Consulting and Release Agreement, dated October 6, 2022, by and between PharmaCyte Biotech, Inc. and Kenneth L. Waggoner (Filed With SEC on October 7, 2022)
Amended and Restated Executive Compensation Agreement, dated May 8, 2022, between Kenneth L. Waggoner and the Company (Filed With SEC on July 28, 2022)
Amended and Restated Executive Compensation Agreement, dated May 8, 2022, between Carlos A. Trujillo and the Company (Filed With SEC on July 28, 2022)
PharmaCyte Biotech, Inc. 2021 Equity Incentive Plan (Filed With SEC on July 28, 2022)
Amendment No. 3, dated as of October 14, 2020, to Executive Compensation Agreement between Gerald W. Crabtree and the Company (Filed With SEC on October 16, 2020)